BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

952 related articles for article (PubMed ID: 18039092)

  • 1. Endocrine functions of adipose tissue.
    Waki H; Tontonoz P
    Annu Rev Pathol; 2007; 2():31-56. PubMed ID: 18039092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipose tissue dysfunction contributes to obesity related metabolic diseases.
    Blüher M
    Best Pract Res Clin Endocrinol Metab; 2013 Apr; 27(2):163-77. PubMed ID: 23731879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipose tissue dysfunction in obesity.
    Blüher M
    Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):241-50. PubMed ID: 19358089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of adipokines in formation of lipid and carbohydrate metabolic disorders in patients with cardiovascular disease].
    Kravchun P; Kadykova O; Gabisoniia T
    Georgian Med News; 2012 Dec; (213):26-31. PubMed ID: 23293229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress and lipid peroxidation by-products at the crossroad between adipose organ dysregulation and obesity-linked insulin resistance.
    Murdolo G; Piroddi M; Luchetti F; Tortoioli C; Canonico B; Zerbinati C; Galli F; Iuliano L
    Biochimie; 2013 Mar; 95(3):585-94. PubMed ID: 23274128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipose tissue inflammation in obesity and metabolic syndrome.
    Nishimura S; Manabe I; Nagai R
    Discov Med; 2009 Aug; 8(41):55-60. PubMed ID: 19788868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From leptin to other adipokines in health and disease: facts and expectations at the beginning of the 21st century.
    Blüher M; Mantzoros CS
    Metabolism; 2015 Jan; 64(1):131-45. PubMed ID: 25497344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipokines in inflammation, insulin resistance and cardiovascular disease.
    Li ZY; Wang P; Miao CY
    Clin Exp Pharmacol Physiol; 2011 Dec; 38(12):888-96. PubMed ID: 21910745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
    Chan JC; Tong PC; Critchley JA
    Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of adipocytokines in obesity-associated insulin resistance.
    Zou C; Shao J
    J Nutr Biochem; 2008 May; 19(5):277-86. PubMed ID: 18054218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflamed adipose tissue, insulin resistance and vascular injury.
    Andersson CX; Gustafson B; Hammarstedt A; Hedjazifar S; Smith U
    Diabetes Metab Res Rev; 2008; 24(8):595-603. PubMed ID: 18756581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adipokines in health and disease.
    Fasshauer M; Blüher M
    Trends Pharmacol Sci; 2015 Jul; 36(7):461-70. PubMed ID: 26022934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity and metabolic syndrome: an inflammatory condition.
    Scarpellini E; Tack J
    Dig Dis; 2012; 30(2):148-53. PubMed ID: 22722429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotactic cytokines, obesity and type 2 diabetes: in vivo and in vitro evidence for a possible causal correlation?
    Sell H; Eckel J
    Proc Nutr Soc; 2009 Nov; 68(4):378-84. PubMed ID: 19698204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of adipokine secretion by n-3 fatty acids.
    Moreno-Aliaga MJ; Lorente-Cebrián S; Martínez JA
    Proc Nutr Soc; 2010 Aug; 69(3):324-32. PubMed ID: 20540825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-talk between adipose tissue and vasculature: role of adiponectin.
    Li FY; Cheng KK; Lam KS; Vanhoutte PM; Xu A
    Acta Physiol (Oxf); 2011 Sep; 203(1):167-80. PubMed ID: 21062420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.
    Cusi K
    Gastroenterology; 2012 Apr; 142(4):711-725.e6. PubMed ID: 22326434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into adipose tissue dysfunction in insulin resistance.
    Mlinar B; Marc J
    Clin Chem Lab Med; 2011 Sep; 49(12):1925-35. PubMed ID: 21892913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 2 diabetes and cardiovascular disease: getting to the fat of the matter.
    Goralski KB; Sinal CJ
    Can J Physiol Pharmacol; 2007 Jan; 85(1):113-32. PubMed ID: 17487251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipokine inflammation and insulin resistance: the role of glucose, lipids and endotoxin.
    Piya MK; McTernan PG; Kumar S
    J Endocrinol; 2013 Jan; 216(1):T1-T15. PubMed ID: 23160966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.